IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 199 filers reported holding IMPAX LABORATORIES INC in Q3 2016. The put-call ratio across all filers is 1,411.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,000 | -100.0% | 83 | -99.9% | 0.00% | -100.0% |
| Q1 2016 | $4,949,000 | -20.9% | 154,561 | +5.6% | 0.11% | -35.7% |
| Q4 2015 | $6,259,000 | +21.4% | 146,376 | 0.0% | 0.17% | +21.3% |
| Q3 2015 | $5,154,000 | -26.1% | 146,376 | -3.7% | 0.14% | -17.1% |
| Q2 2015 | $6,976,000 | -44.4% | 151,923 | -43.2% | 0.17% | -47.7% |
| Q1 2015 | $12,538,000 | +70.2% | 267,500 | +15.1% | 0.32% | +72.0% |
| Q4 2014 | $7,366,000 | +33.6% | 232,500 | 0.0% | 0.19% | +25.2% |
| Q3 2014 | $5,513,000 | -27.6% | 232,500 | -8.5% | 0.15% | -30.4% |
| Q2 2014 | $7,617,000 | +91.6% | 253,977 | +68.8% | 0.22% | +68.2% |
| Q1 2014 | $3,976,000 | – | 150,500 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |